A detailed history of Patriot Financial Group Insurance Agency, LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Patriot Financial Group Insurance Agency, LLC holds 19,000 shares of PBYI stock, worth $57,380. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,000
Previous 11,000 72.73%
Holding current value
$57,380
Previous $35,000 37.14%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$2.25 - $4.03 $18,000 - $32,240
8,000 Added 72.73%
19,000 $48,000
Q2 2024

Jul 26, 2024

SELL
$2.92 - $5.83 $1,460 - $2,915
-500 Reduced 4.35%
11,000 $35,000
Q1 2024

Apr 30, 2024

SELL
$4.29 - $7.4 $98,670 - $170,200
-23,000 Reduced 66.67%
11,500 $60,000
Q4 2023

Jan 19, 2024

SELL
$2.23 - $4.49 $72,475 - $145,925
-32,500 Reduced 48.51%
34,500 $149,000
Q3 2023

Oct 19, 2023

BUY
$2.63 - $4.09 $5,260 - $8,180
2,000 Added 3.08%
67,000 $176,000
Q2 2023

Jul 17, 2023

BUY
$2.6 - $3.58 $75,400 - $103,820
29,000 Added 80.56%
65,000 $229,000
Q1 2023

Apr 20, 2023

BUY
$2.21 - $4.82 $16,575 - $36,150
7,500 Added 26.32%
36,000 $111,000
Q4 2022

Jan 17, 2023

SELL
$2.12 - $5.08 $46,640 - $111,760
-22,000 Reduced 43.56%
28,500 $0
Q3 2022

Oct 31, 2022

SELL
$2.27 - $3.84 $11,350 - $19,200
-5,000 Reduced 9.01%
50,500 $120,000
Q1 2022

May 11, 2022

SELL
$2.13 - $3.24 $8,520 - $12,960
-4,000 Reduced 6.72%
55,500 $160,000
Q4 2021

Jan 10, 2022

BUY
$2.85 - $6.58 $169,575 - $391,510
59,500 New
59,500 $181,000

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $138M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.